Moderna (NASDAQ: MRNA) reported Q3 EPS of $2.53, $2.28 worse than the analyst estimate of $4.81. Revenue for the quarter came in at $3.36 billion versus the consensus estimate of $4.63 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.